medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2010, Number 93

<< Back Next >>

Rev Enfer Infec Pediatr 2010; 23.24 (93)

Hospitalizations in children infected with human immunodeficiency virus

Quian J, González V, Galínde C, Gutiérrez S

Language: Spanish
References: 27
Page: 25-30
PDF size: 1132.28 Kb.


ABSTRACT

Background: in almost 30 years of HIV’s pandemic there have been substantial changes in the diagnosis and treatment of the infected children. From 1997 in Uruguay it was begun by the HAART.
Objective: to analyze in prospective form the children’s infected with HIV hospitalizations and to compare with previous study Material and methods: in the period included between May 01, 2006 and April 30, 2008 there was analyzed the hospitalization of the children infected with HIV in the CHPR. Information was gathered: age, sex, weight, height, reason of the hospitalization, level of CD4, treatment, immunizations, days of hospitalization, need of intensive care, discharge or death.
Results: there were included 42 children, who had in whole 72 hospitalizations. The median of days of hospitalization was of 6 and the median of age to the admission was 5 years. 58% was well nourished and the most important cause of hospitalization was respiratory infections; 68% was immunocompetent, 53% was receiving HAART; 7 children needed intensive care. With regard to the previous study it increased the median age to the admission, diminished the percentage with chronic malnutrition, increased the number of children with normal CD4 and no patient died.
Conclusion: in the comparison of both studies a decrease of the hospitalization has been obvious in children with one year old or less, having changed the middle ages of hospitalization from 14 months to 5 years. The patients diminished with immunosupression and also those who were presenting chronic malnutrition. The levels of immunization must be improved


REFERENCES

  1. Blanche S, Rouzioux C, Guihard ML, Veber F, Mayaux MJ, Jacomet C, et al. A prospective study of infants born to women seropositive for HIV type-1. N Engl J Med 1989;320:1643-8.

  2. Tovo P, de Martino M, Gabiano C, Cappello N, D’Elia R, Loy A, et al. Prognostic factors and survival in children with perinatal HIV-1infection. Lancet 1992;3391:249-53.

  3. The European collaborative study. Natural history of vertically acquired HIV-1 infection. Pediatrics 1994;94:815-9.

  4. Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M, et al. Combination treatment with zidovudine, didanosine and nevirapine in infants with HIV type 1 infection. N Engl J Med 1997;336:1343-9.

  5. Mueller B, Nelson R, Sleasman J, Zuckerman J, Heath-Chozzi M, Steinber S, et al. A phase I/II study of the protease inhibitor ritonavir in children with HIV infection. Pediatrics 1998;101:335-43.

  6. Kline M, Van Dyke R, Lindsey J, Gwyne M, Culnane M, Diaz C, et al. Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with HIV infection. Pediatrics 1999;103(5);e62.

  7. Tudor-Williams G. Use of antiretrovirals in children. J HIV Therapy 1999;4(3):68-73.

  8. De Martino M, Tovo P, Balducci M, Galli L, Gabiano C, Rezza G, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. JAMA 2000;284:190-7.

  9. Gortmaker S, Hughes M, Cervia J, Brady M, Johnson G, Seage G, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001;345:1522-8.

  10. Kourtis A, Bansil P, Posner S, Jonson C, Jamieson D. Trends in hospitalizations of HIV-infected children and adolescents in the United States: analysis of data from the 1994-2003 nationwide inpatient sample. Pediatrics 2007;120:e236- e243.

  11. Viani R, Araneta M, Deville J, Spector S. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Cl Infect Dis 2004;39:725-31.

  12. Berni R, Spagnuolo M, Cirillo P, Guarino A. Decreased needs for hospital care and antibiotics in children with advanced HIV-1 disease after protease inhibitor-containing combination therapy. AIDS 1999;13(8):1005-6.

  13. Quian J, Gutierrez S, Pujadas M, Gonzalez V, Mas M, Parodi A, Schelotto M. Hospitalizaciones de niños infectados por el virus de la inmunodeficiencia humana. Arch Pediatr Urug 2008;79(2):105-12.

  14. Lucas J, Severi C, Aldabe I, Girona A. Evaluación antropométrica del niño. Montevideo: Oficina del Libro. AEM, 2000.

  15. CDC. 1994 Revised classification system for HIV infection in children less than 13 years of age MMWR 1994;43(no. RR-12):1-10.

  16. Quian J, Visconti A, Gutierrez S, Galli A, Maturo M, Galeano V, et al. Detección de infección por VIH a través de test rápido en mujeres embarazadas; una estrategia exitosa para disminuir la transmisión vertical. Rev Chil Infect 2005;22(4):321-6.

  17. Quian J, Gutierrez S, Picón T, Visconti A, Gonzalez A, Nin M, Martín J, et al. Transmisión madre-hijo del VIH según quimioprofilaxis recibida, vía de nacimiento y amamantamiento. Rev Med Urug 2002;18:265-9.

  18. Quian J, Gutierrez S, Zabala C, Gonzalez V, Bernadá E, Guimil S, et al. Oportunidades perdidas para evitar la transmisión materno-infantil del VIH Uruguay, 2005-2007. Rev Med Urug 2009;25:27-33.

  19. Sullivan J, Luzuriaga K. The changing FACE of pediatric HIV-1 infection. N Engl J Med 2001;345(21):1568-9.

  20. Simpson J, Shapiro E, Andiman W. Prospective cohort study of children born to HIV-infected mothers, 1985 through 1997: trends in the risk of vertical transmission, mortality and acquired immunodeficiency syndrome indicator diseases in the era before highly active antiretroviral therapy. Pediatr Infect Dis J 2000;19:618-24.

  21. Kourtis A, Paramsothy P, Posner S, Meikle S, Jamieson D. National estimates of hospital use by children with HIV infection in the United Sates: analysis of data from the 2000 KIDS inpatient database. Pediatrics 2006;118:e167-e173.

  22. Mulenga V, Ford D, Walker S, Mwenya D, Mwansa J, Sinyinza F, et al. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children. AIDS 2007;21:77-84.

  23. Judd A, Doerholt K, Tookey P, Sharland M, Riordan A, Menson E, et al. Morbidity, mortality and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis 2007;45:918-24.

  24. Puthanakit T, Aurpibul L, Oberdorfer P, Akarathum N, Kanjananit S, Wannarit P, et al. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Cl Infect Dis 2007;44:599-604.

  25. Janssens B, Raleigh B, Soeung S, Asao K, Te V, Gupta J, et al. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics 2007;120(5):e1134-e1140.

  26. Patel K, Hernán M, Williams P, Seeger J, McIntosh K, Van Dyke R, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Cl. Infect Dis 2008;46:507-15.

  27. The European Collaborative Study Hospitalization of children born to HIV-infected women in Europe. Pediatr. Infect Dis J 1997;16:1151-6.




2020     |     www.medigraphic.com